MSA
MYGN icon

Mason Street Advisors’s Myriad Genetics MYGN Stock Holding History

Mason Street Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28,046
Closed -$555K – 795
2020
Q4 		$555K Buy
28,046
+17
+0.1% +$275 0.01% 1134
2020
Q3 		$365K Buy
28,029
+39
+0.1% +$494 0.01% 1187
2020
Q2 		$317K Buy
27,990
+2,080
+8% +$29.5K 0.01% 1219
2020
Q1 		$371K Hold
25,910
– – 0.01% 1094
2019
Q4 		$706K Buy
25,910
+828
+3% +$22.8K 0.01% 1014
2019
Q3 		$718K Buy
25,082
+590
+2% +$17.2K 0.01% 978
2019
Q2 		$680K Buy
24,492
+960
+4% +$27.1K 0.01% 999
2019
Q1 		$781K Buy
23,532
+315
+1% +$9.59K 0.02% 980
2018
Q4 		$675K Buy
23,217
+2,203
+10% +$79.3K 0.02% 946
2018
Q3 		$967K Buy
21,014
+827
+4% +$36.8K 0.02% 887
2018
Q2 		$754K Buy
20,187
+810
+4% +$27.4K 0.02% 955
2018
Q1 		$573K Buy
19,377
+1,368
+8% +$46.3K 0.01% 996
2017
Q4 		$619K Buy
18,009
+676
+4% +$22.8K 0.01% 964
2017
Q3 		$627K Buy
17,333
+535
+3% +$15.3K 0.01% 953
2017
Q2 		$434K Buy
16,798
+876
+6% +$18.6K 0.01% 1035
2017
Q1 		$306K Buy
+15,922
New +$282K 0.01% 1129
2015
Q1 		– Sell
-7,090
Closed -$241K – 1656
2014
Q4 		$241K Sell
7,090
-340
-5% -$12.1K ﹤0.01% 1443
2014
Q3 		$287K Hold
7,430
– – ﹤0.01% 1412
2014
Q2 		$289K Sell
7,430
-1,120
-13% -$41.7K ﹤0.01% 1399
2014
Q1 		$292K Sell
8,550
-840
-9% -$26K ﹤0.01% 1373
2013
Q4 		$197K Sell
9,390
-240
-2% -$6.07K ﹤0.01% 1516
2013
Q3 		$226K Sell
9,630
-6,220
-39% -$177K ﹤0.01% 1272
2013
Q2 		$426K Buy
+15,850
New +$459K ﹤0.01% 1082

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Mason Street Advisors's MYGN Position: Q1 2021 in Review

Mason Street Advisors sold out of Myriad Genetics (MYGN) in Q1 2021, closing a stake of 28,046 shares — an estimated $555K sold.

Mason Street Advisors first reported a position in MYGN in Q2 2013 and held it in 23 quarters. The position peaked at $967K in Q3 2018. 197 funds tracked by Wall St. Rank hold MYGN as of Q1 2021.

  • Mason Street Advisors reported no remaining Myriad Genetics position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 28,046 Myriad Genetics shares in Q1 2021, an estimated $555K.
  • Mason Street Advisors first reported a position in Myriad Genetics in Q2 2013 and held it in 23 quarters.
  • Mason Street Advisors's Myriad Genetics position peaked at $967K in Q3 2018.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.